Press Release

Biosimilars market 2019-2025 Assessment, Opportunities, Insight, Trends, Key Players Teva Pharmaceuticals, Sandoz AG, and Pfizer


Biosimilars Market Research Report 2019

Biosimilars are the biologic pharmaceuticals which are similar to the reference biologic products. These drugs are similar to biological products which contains synthetically manufactured protein molecules. When the patent of brand drug is expired, manufacturers are planning to develop off-patent biologics like biosimilars that offer similar biological activity. The biosimilars industry offers various opportunities to the manufacturers owing to associated advantages.As per the various research studies, biosimilars reduce drug development cost up to 20%-25% compared to the originator products owing to the reduced clinical trials. Thus, several companies such as Teva Pharmaceutical, Hospira, Inc., and Amgen are in constant efforts to develop biosimilar. For which, these companies are rigorously increasing their research and development expenses on clinical trials to introduce novel biosimilars. For example, Amgen has a strong product pipeline under biosimilar segment such as ABP 798 (biosimilar rituximab), ABP 710 (biosimilar infliximab), and ABP 215 (biosimilar bevacizumab). Furthermore, increasing incidences of chronic diseases coupled with large number of blockbuster biologics (e.g. Enbrel, and Remicade) going off patent support the industry growth significantly. However, strict regulations and high cost for R&D activities will hamper the market growth.Likewise, the report caters detailed analytical overview of Biosimilars market in order to make readers aware about latest industry trends. It also reveals key elements which covers leading consumers, raw material suppliers, and manufacturing equipment suppliers.

Top Key Players Covered in this report – Teva Pharmaceuticals, Sandoz AG, and Pfizer

Request a Sample copy of this report @

In terms of products, the market report covers the following segments: TYPESRecombinant Glycosylated ProteinsRecombinant Non-Glycosylated Proteins

By the Application, the market is primarily split into:OncologyBlood DisordersInfectious DiseasesAutoimmune DiseasesOthersThe research study includes in-depth analysis where important segments and regional data are studied in quite some detail. It also provides market channel, distribution & customer analysis, industry cost analysis, organization profiles, market analysis by production & revenue, price trend analysis by type as well as production and consumption analysis by region, and various other market studies.The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, Asia Pacific, Middle East and Africa after evaluating political, economic, social and technological factors of Biosimilars market.

Buy Full Report @

Reasons to buy the report

  • Make readers aware about Biosimilars and the success of this market.
  • Information regarding emerging and developed markets where Biosimilars market have established their foot.
  • Determination of restrains and how to overcome them.
  • Strategies as per the drivers, trends and segment highlights.
  • Identify the work flow through value chain evaluation.
  • Identify market key players, for making strategies accordingly.
  • Know about the steps and strategies built by biggies for shaping future growth.
  • Evaluate your brand position in the market by considering the position of products and services of leading competitors in the market.

For More Details On this Report: @

Contact Us:
Analyst View Market insights

[email protected]
+1 615-326-5253 

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, and Europe.